Cargando…
Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study
To investigate the blood pressure (BP)–lowering effect of olmesartan in relation to chronic kidney disease (CKD)–associated sympathetic nerve activity, a subanalysis was performed using data from the first 16 weeks of the Home BP Measurement With Olmesartan‐Naive Patients to Establish Standard Targe...
Autores principales: | Kario, Kazuomi, Saito, Ikuo, Kushiro, Toshio, Teramukai, Satoshi, Mori, Yoshihiro, Hiramatsu, Katsutoshi, Kobayashi, Fumiaki, Shimada, Kazuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884768/ https://www.ncbi.nlm.nih.gov/pubmed/23889717 http://dx.doi.org/10.1111/jch.12132 |
Ejemplares similares
-
Persistent olmesartan-based blood pressure–lowering effects on morning hypertension in Asians: the HONEST study
por: Kario, Kazuomi, et al.
Publicado: (2016) -
Effects of Olmesartan‐Based Treatment on Masked, White‐Coat, Poorly Controlled, and Well‐Controlled Hypertension: HONEST Study
por: Kario, Kazuomi, et al.
Publicado: (2014) -
Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study
por: Saito, Ikuo, et al.
Publicado: (2013) -
Differences between clinic blood pressure and morning home blood pressure, as shown by Bland–Altman plots, in a large observational study (HONEST study)
por: Shimada, Kazuyuki, et al.
Publicado: (2015) -
Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension
por: Kushiro, Toshio, et al.
Publicado: (2015)